Crystalline Forms Of A Prolyl Hydroxylase Inhibitor

Patent No. EP2872488 (titled "Crystalline Forms Of A Prolyl Hydroxylase Inhibitor") was filed by Fibrogen on Jul 15, 2013. The application was issued on Aug 22, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZMay 22, 2019TER MEER STEINMEISTER & PARTNER
TEVA PHARMACEUTICALSMay 21, 2019D YOUNG
ZENTIVAMay 20, 2019KRAUS & LEDERER
ZENTIVAMay 20, 2019KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2872488

FIBROGEN
Application Number
EP13740185A
Filing Date
Jul 15, 2013
Status
Revoked
Apr 12, 2024
Publication Date
Aug 22, 2018